OR WAIT null SECS
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
Effective analytics will eliminate failures, deviations, and non-conformances.
January 02, 2012
The European Union market takes steps toward continuous processing and modular facilities.
December 21, 2011
PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the December 2011 edition from Banner Engineering and Eriez.
Risk assessment is not a new concept to the pharmaceutical industry, but lately the phrase has become a mantra. A systemic, science-based way to manage risk is becoming essential to meeting the spirit and letter of FDA requirements.
December 02, 2011
Cleanliness is crucial, even if zapping and trapping is necessary to reduce product contamination.
The seventh in a series of eight case studies from the Product Quality Research Institute focuses on packout remedies.
Drug shortages, supply-chain security, generic-drug incursion, and flexible manufacturing models are some of the issues shaping the bio/pharma industry.
Precedents set in the historic Barr case continue to raise questions over suitable sample-size criteria.
Readers react to the economic turmoil of the past year and look longingly forward to 2012.
The last in a series of eight case studies from the Product Quality Research Institute focuses on internal GMP audits.
The sixth in a series of eight case studies from the Product Quality Research Institute focuses on packaging line GMP optimization.